nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Vincristine—muscle cancer	0.143	0.17	CbGbCtD
Spironolactone—ABCC2—Etoposide—muscle cancer	0.131	0.156	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—muscle cancer	0.104	0.124	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—muscle cancer	0.0893	0.106	CbGbCtD
Spironolactone—ABCC2—Methotrexate—muscle cancer	0.0865	0.103	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—muscle cancer	0.0756	0.0901	CbGbCtD
Spironolactone—CYP2C8—Etoposide—muscle cancer	0.063	0.0751	CbGbCtD
Spironolactone—ABCB1—Vincristine—muscle cancer	0.0466	0.0555	CbGbCtD
Spironolactone—ABCB1—Etoposide—muscle cancer	0.0427	0.0509	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—muscle cancer	0.0291	0.0347	CbGbCtD
Spironolactone—ABCB1—Methotrexate—muscle cancer	0.0282	0.0336	CbGbCtD
Spironolactone—AR—scrotum—muscle cancer	0.0239	0.233	CbGeAlD
Spironolactone—SHBG—hindlimb—muscle cancer	0.0113	0.111	CbGeAlD
Spironolactone—CYP11B2—renal system—muscle cancer	0.00536	0.0524	CbGeAlD
Spironolactone—NR3C2—smooth muscle tissue—muscle cancer	0.00246	0.024	CbGeAlD
Spironolactone—NR3C2—renal system—muscle cancer	0.00237	0.0231	CbGeAlD
Spironolactone—PGR—smooth muscle tissue—muscle cancer	0.00228	0.0223	CbGeAlD
Spironolactone—NR3C2—cardiac atrium—muscle cancer	0.00212	0.0207	CbGeAlD
Spironolactone—SLCO1A2—renal system—muscle cancer	0.00203	0.0198	CbGeAlD
Spironolactone—ABCC2—renal system—muscle cancer	0.00189	0.0185	CbGeAlD
Spironolactone—NR3C2—tendon—muscle cancer	0.00185	0.0181	CbGeAlD
Spironolactone—SHBG—bone marrow—muscle cancer	0.00185	0.0181	CbGeAlD
Spironolactone—AR—smooth muscle tissue—muscle cancer	0.00182	0.0178	CbGeAlD
Spironolactone—SHBG—vagina—muscle cancer	0.00177	0.0173	CbGeAlD
Spironolactone—AR—renal system—muscle cancer	0.00175	0.0171	CbGeAlD
Spironolactone—Ulcer—Dactinomycin—muscle cancer	0.00173	0.0294	CcSEcCtD
Spironolactone—NR3C2—vagina—muscle cancer	0.00171	0.0168	CbGeAlD
Spironolactone—NR3C1—embryo—muscle cancer	0.00168	0.0164	CbGeAlD
Spironolactone—PGR—vagina—muscle cancer	0.00159	0.0156	CbGeAlD
Spironolactone—NR3C2—head—muscle cancer	0.00158	0.0155	CbGeAlD
Spironolactone—SHBG—testis—muscle cancer	0.00158	0.0154	CbGeAlD
Spironolactone—AR—cardiac atrium—muscle cancer	0.00157	0.0153	CbGeAlD
Spironolactone—NR3C2—testis—muscle cancer	0.00153	0.015	CbGeAlD
Spironolactone—ABCC2—tendon—muscle cancer	0.00147	0.0144	CbGeAlD
Spironolactone—PGR—head—muscle cancer	0.00147	0.0144	CbGeAlD
Spironolactone—PGR—testis—muscle cancer	0.00142	0.0139	CbGeAlD
Spironolactone—CYP2C8—renal system—muscle cancer	0.00142	0.0139	CbGeAlD
Spironolactone—AR—tendon—muscle cancer	0.00137	0.0134	CbGeAlD
Spironolactone—SLCO1A2—head—muscle cancer	0.00136	0.0133	CbGeAlD
Spironolactone—NR3C1—smooth muscle tissue—muscle cancer	0.00132	0.0129	CbGeAlD
Spironolactone—SLCO1A2—testis—muscle cancer	0.00131	0.0128	CbGeAlD
Spironolactone—AR—vagina—muscle cancer	0.00127	0.0124	CbGeAlD
Spironolactone—NR3C1—renal system—muscle cancer	0.00127	0.0124	CbGeAlD
Spironolactone—Ulcer—Etoposide—muscle cancer	0.00126	0.0213	CcSEcCtD
Spironolactone—ABCC2—testis—muscle cancer	0.00122	0.0119	CbGeAlD
Spironolactone—Lethargy—Dactinomycin—muscle cancer	0.00121	0.0206	CcSEcCtD
Spironolactone—AR—head—muscle cancer	0.00117	0.0115	CbGeAlD
Spironolactone—NR3C1—cardiac atrium—muscle cancer	0.00114	0.0111	CbGeAlD
Spironolactone—AR—testis—muscle cancer	0.00113	0.0111	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00107	0.0182	CcSEcCtD
Spironolactone—CYP2C8—vagina—muscle cancer	0.00103	0.01	CbGeAlD
Spironolactone—Ataxia—Vincristine—muscle cancer	0.001	0.017	CcSEcCtD
Spironolactone—NR3C1—tendon—muscle cancer	0.000991	0.00969	CbGeAlD
Spironolactone—NR3C1—bone marrow—muscle cancer	0.00096	0.00938	CbGeAlD
Spironolactone—NR3C1—vagina—muscle cancer	0.000919	0.00899	CbGeAlD
Spironolactone—CYP2C8—testis—muscle cancer	0.000916	0.00896	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00091	0.0154	CcSEcCtD
Spironolactone—ABCB1—embryo—muscle cancer	0.000898	0.00878	CbGeAlD
Spironolactone—Agranulocytosis—Dactinomycin—muscle cancer	0.000856	0.0145	CcSEcCtD
Spironolactone—NR3C1—head—muscle cancer	0.000849	0.0083	CbGeAlD
Spironolactone—Erectile dysfunction—Vincristine—muscle cancer	0.000847	0.0144	CcSEcCtD
Spironolactone—NR3C1—testis—muscle cancer	0.00082	0.00802	CbGeAlD
Spironolactone—Rash erythematous—Doxorubicin—muscle cancer	0.000804	0.0137	CcSEcCtD
Spironolactone—Erythema multiforme—Dactinomycin—muscle cancer	0.000779	0.0132	CcSEcCtD
Spironolactone—Cramp muscle—Etoposide—muscle cancer	0.000776	0.0132	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000776	0.0132	CcSEcCtD
Spironolactone—Ulcer—Methotrexate—muscle cancer	0.000752	0.0128	CcSEcCtD
Spironolactone—Vasculitis—Methotrexate—muscle cancer	0.000729	0.0124	CcSEcCtD
Spironolactone—Alopecia—Dactinomycin—muscle cancer	0.000728	0.0124	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—muscle cancer	0.000706	0.012	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—muscle cancer	0.000701	0.0119	CcSEcCtD
Spironolactone—ABCB1—renal system—muscle cancer	0.000679	0.00664	CbGeAlD
Spironolactone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000665	0.0113	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000658	0.0112	CcSEcCtD
Spironolactone—Renal failure—Etoposide—muscle cancer	0.000653	0.0111	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—muscle cancer	0.000651	0.0111	CcSEcCtD
Spironolactone—Alopecia—Vincristine—muscle cancer	0.00065	0.011	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—muscle cancer	0.000647	0.011	CcSEcCtD
Spironolactone—Leukopenia—Dactinomycin—muscle cancer	0.000642	0.0109	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—muscle cancer	0.000636	0.0108	CcSEcCtD
Spironolactone—Agranulocytosis—Etoposide—muscle cancer	0.00062	0.0105	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—muscle cancer	0.000605	0.0103	CcSEcCtD
Spironolactone—Discomfort—Dactinomycin—muscle cancer	0.000603	0.0102	CcSEcCtD
Spironolactone—Leukopenia—Vincristine—muscle cancer	0.000573	0.00974	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—muscle cancer	0.000573	0.00973	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000566	0.00961	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—muscle cancer	0.000564	0.00957	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—muscle cancer	0.000559	0.00949	CcSEcCtD
Spironolactone—Alopecia—Etoposide—muscle cancer	0.000527	0.00895	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—muscle cancer	0.000527	0.00894	CcSEcCtD
Spironolactone—Anaphylactic shock—Vincristine—muscle cancer	0.000523	0.00888	CcSEcCtD
Spironolactone—ABCB1—bone marrow—muscle cancer	0.000514	0.00502	CbGeAlD
Spironolactone—Thrombocytopenia—Vincristine—muscle cancer	0.000512	0.00869	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—muscle cancer	0.000499	0.00847	CcSEcCtD
Spironolactone—ABCB1—vagina—muscle cancer	0.000492	0.00481	CbGeAlD
Spironolactone—Ataxia—Methotrexate—muscle cancer	0.000485	0.00824	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—muscle cancer	0.000484	0.00822	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—muscle cancer	0.000482	0.00819	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—muscle cancer	0.000481	0.00818	CcSEcCtD
Spironolactone—Malaise—Etoposide—muscle cancer	0.000468	0.00795	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000465	0.00789	CcSEcCtD
Spironolactone—Leukopenia—Etoposide—muscle cancer	0.000465	0.00789	CcSEcCtD
Spironolactone—Body temperature increased—Dactinomycin—muscle cancer	0.000463	0.00786	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—muscle cancer	0.000456	0.00775	CcSEcCtD
Spironolactone—ABCB1—head—muscle cancer	0.000455	0.00445	CbGeAlD
Spironolactone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000451	0.00767	CcSEcCtD
Spironolactone—Eosinophilia—Methotrexate—muscle cancer	0.000442	0.0075	CcSEcCtD
Spironolactone—ABCB1—testis—muscle cancer	0.000439	0.00429	CbGeAlD
Spironolactone—Discomfort—Etoposide—muscle cancer	0.000437	0.00741	CcSEcCtD
Spironolactone—Hypersensitivity—Dactinomycin—muscle cancer	0.000431	0.00732	CcSEcCtD
Spironolactone—Confusional state—Etoposide—muscle cancer	0.000427	0.00725	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—muscle cancer	0.000424	0.00719	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—muscle cancer	0.00042	0.00714	CcSEcCtD
Spironolactone—Thrombocytopenia—Etoposide—muscle cancer	0.000415	0.00704	CcSEcCtD
Spironolactone—Body temperature increased—Vincristine—muscle cancer	0.000413	0.00702	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—muscle cancer	0.000411	0.00698	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000402	0.00683	CcSEcCtD
Spironolactone—Diarrhoea—Dactinomycin—muscle cancer	0.0004	0.0068	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—muscle cancer	0.000398	0.00675	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—muscle cancer	0.000396	0.00672	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000394	0.0067	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—muscle cancer	0.000391	0.00664	CcSEcCtD
Spironolactone—Hypersensitivity—Vincristine—muscle cancer	0.000385	0.00654	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—muscle cancer	0.000382	0.0065	CcSEcCtD
Spironolactone—Somnolence—Etoposide—muscle cancer	0.000377	0.00639	CcSEcCtD
Spironolactone—Vomiting—Dactinomycin—muscle cancer	0.000372	0.00632	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—muscle cancer	0.000371	0.0063	CcSEcCtD
Spironolactone—Rash—Dactinomycin—muscle cancer	0.000369	0.00627	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000366	0.00621	CcSEcCtD
Spironolactone—Diarrhoea—Vincristine—muscle cancer	0.000358	0.00607	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—muscle cancer	0.000349	0.00593	CcSEcCtD
Spironolactone—Nausea—Dactinomycin—muscle cancer	0.000348	0.0059	CcSEcCtD
Spironolactone—Dizziness—Vincristine—muscle cancer	0.000346	0.00587	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—muscle cancer	0.000344	0.00585	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000341	0.0058	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—muscle cancer	0.000339	0.00575	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—muscle cancer	0.000338	0.00573	CcSEcCtD
Spironolactone—Urticaria—Etoposide—muscle cancer	0.000336	0.00571	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—muscle cancer	0.000335	0.00569	CcSEcCtD
Spironolactone—Vomiting—Vincristine—muscle cancer	0.000332	0.00565	CcSEcCtD
Spironolactone—Rash—Vincristine—muscle cancer	0.00033	0.0056	CcSEcCtD
Spironolactone—Dermatitis—Vincristine—muscle cancer	0.000329	0.00559	CcSEcCtD
Spironolactone—Headache—Vincristine—muscle cancer	0.000328	0.00556	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—muscle cancer	0.000321	0.00546	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—muscle cancer	0.000316	0.00536	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—muscle cancer	0.000312	0.0053	CcSEcCtD
Spironolactone—Nausea—Vincristine—muscle cancer	0.000311	0.00527	CcSEcCtD
Spironolactone—Pruritus—Etoposide—muscle cancer	0.0003	0.00509	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—muscle cancer	0.000292	0.00496	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—muscle cancer	0.00029	0.00492	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—muscle cancer	0.000288	0.0049	CcSEcCtD
Spironolactone—Malaise—Methotrexate—muscle cancer	0.00028	0.00476	CcSEcCtD
Spironolactone—Dizziness—Etoposide—muscle cancer	0.00028	0.00476	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—muscle cancer	0.000278	0.00473	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—muscle cancer	0.000273	0.00464	CcSEcCtD
Spironolactone—Vomiting—Etoposide—muscle cancer	0.000269	0.00457	CcSEcCtD
Spironolactone—Rash—Etoposide—muscle cancer	0.000267	0.00453	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—muscle cancer	0.000267	0.00453	CcSEcCtD
Spironolactone—Headache—Etoposide—muscle cancer	0.000265	0.00451	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—muscle cancer	0.000261	0.00444	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—muscle cancer	0.000259	0.00439	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—muscle cancer	0.000256	0.00434	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—muscle cancer	0.000254	0.00431	CcSEcCtD
Spironolactone—Nausea—Etoposide—muscle cancer	0.000252	0.00427	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—muscle cancer	0.00025	0.00424	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—muscle cancer	0.000248	0.00422	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—muscle cancer	0.000243	0.00412	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—muscle cancer	0.000241	0.00409	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—muscle cancer	0.000226	0.00384	CcSEcCtD
Spironolactone—Somnolence—Methotrexate—muscle cancer	0.000226	0.00383	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—muscle cancer	0.000221	0.00376	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—muscle cancer	0.00022	0.00373	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000219	0.00372	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000215	0.00365	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—muscle cancer	0.000209	0.00355	CcSEcCtD
Spironolactone—Urticaria—Methotrexate—muscle cancer	0.000202	0.00342	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—muscle cancer	0.000201	0.00341	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—muscle cancer	0.000195	0.00332	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00019	0.00322	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—muscle cancer	0.000187	0.00317	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—muscle cancer	0.000181	0.00307	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—muscle cancer	0.000179	0.00305	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—muscle cancer	0.000175	0.00296	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—muscle cancer	0.000174	0.00295	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—muscle cancer	0.000174	0.00295	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—muscle cancer	0.000168	0.00285	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—muscle cancer	0.000162	0.00275	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—muscle cancer	0.000161	0.00274	CcSEcCtD
Spironolactone—Rash—Methotrexate—muscle cancer	0.00016	0.00272	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—muscle cancer	0.00016	0.00271	CcSEcCtD
Spironolactone—Headache—Methotrexate—muscle cancer	0.000159	0.0027	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—muscle cancer	0.000155	0.00264	CcSEcCtD
Spironolactone—Nausea—Methotrexate—muscle cancer	0.000151	0.00256	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—muscle cancer	0.00015	0.00255	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—muscle cancer	0.000145	0.00247	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—muscle cancer	0.00014	0.00237	CcSEcCtD
Spironolactone—Rash—Doxorubicin—muscle cancer	0.000139	0.00235	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—muscle cancer	0.000138	0.00235	CcSEcCtD
Spironolactone—Headache—Doxorubicin—muscle cancer	0.000138	0.00234	CcSEcCtD
Spironolactone—Nausea—Doxorubicin—muscle cancer	0.00013	0.00222	CcSEcCtD
